Eleven Biotherapeutics, Inc. (EBIO) stock go down so far this year; showing a decline of -64.68% and dropped with negative flow of -2.24% during recent week. The shares price has positioned -38.11% down over the past quarter while it has directed -50.76% toward a falling position throughout past six months. The shares price has directed -72.01% toward a lower level throughout last year and swapped -37.54% toward a weak spot during past one month.
Eleven Biotherapeutics, Inc. (EBIO) stock is sinking -1.52% to $0.67. EBIO exchanged 0.37 million shares in recent session versus to the average volume of 0.68 million shares while its relative volume is 0.53. Analysts have a mean recommendation of 2.00 on this stock. The company holds 29.71 million outstanding shares and 20.20 million shares are floating in market. Institutional owners hold 24.70% stake in the company, while Insiders ownership held at 18.22%. The stock has a beta value of 3.33. It sustained ROA (TTM) at -28.10%. The stock’s short float is around of 8.70% and short ratio is 2.59.
Moving toward the technical facts, its current distance from 20-Day Simple Moving Average is -6.84% and standing -40.97% away from 50-Day Simple Moving Average while traded down -55.48% from 200-Day Simple Moving Average. The stock has advanced 8.78% to a low over the previous 12 months and showed declining move -75.11% to a high over the same period. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance. They may also be used to assist the trader figure out proper support and resistance levels for the stock.
Why Eleven Biotherapeutics, Inc. (EBIO) is considered oversold?
For further technical study, we took a look at others popular technical indicator Relative Strength Index (RSI). Currently, the 14-day RSI reading is at 29.66. Traditional interpretation and usage of the RSI is that RSI values of 70 or above indicate that a security is becoming overbought or overvalued, and therefore may be primed for a trend reversal or corrective pullback in price. On the other side of RSI values, an RSI reading of 30 or below is commonly interpreted as indicating an oversold or undervalued condition that may signal a trend change or corrective price reversal to the upside.